SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | 0.0% | 115 | -14.8% | 0.00% | – |
| Q4 2021 | $4,000 | -86.2% | 135 | -88.9% | 0.00% | -100.0% |
| Q2 2020 | $29,000 | +625.0% | 1,215 | +631.9% | 0.00% | +200.0% |
| Q4 2019 | $4,000 | -92.9% | 166 | -90.2% | 0.00% | -93.3% |
| Q2 2019 | $56,000 | +300.0% | 1,692 | +324.1% | 0.02% | +150.0% |
| Q1 2019 | $14,000 | +1300.0% | 399 | +1230.0% | 0.01% | – |
| Q4 2018 | $1,000 | -50.0% | 30 | -6.2% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | -81.8% | 32 | -88.7% | 0.00% | -87.5% |
| Q4 2017 | $11,000 | +10.0% | 284 | -27.0% | 0.01% | -20.0% |
| Q4 2016 | $10,000 | – | 389 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |